AI integration into HIV care The Lancet HIV ++... ++

AI integration into HIV care The Lancet HIV https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00009-3/fulltext?dgcid=raven_jbs_etoc_email Feb 2026 Volume 13Number 2e71-e142 https://www.thelancet.com/journals/lanhiv/issue/vol13no2/PIIS2352-3018(26)X2001-X HIV prevalence, risk behaviours, and cascade of care among men who have sex with men in Iran: a nationwide, cross-sectional, biobehavioural survey Mehrdad Khezri, MSca,b,† ∙ Soheil Mehmandoost, MSca,† ∙ Fatemeh Tavakoli, PhDa ∙ Saba Rouhani, PhDb ∙ Fatemeh Mehrabi, PharmDa,c ∙ Elham Nourolahzadeh, MScd ∙ et al. https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00230-9/abstract?dgcid=raven_jbs_etoc_feature_lanhiv Acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial Elizabeth D Lowenthal, MDa,b,* lowenthale@chop.edu ∙ Jennifer Chapman, MPHa ∙ Kristin Baltrusaitis, PhDc ∙ Grace Kovic, MBc ∙ Sanjna Merchantd ∙ Kaleb Branch, BSb ∙ et al. https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00241-3/abstract?dgcid=raven_jbs_etoc_feature_lanhiv